ClinicalTrials.Veeva

Menu

Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France (MRC-Gard)

C

Centre Hospitalier Universitaire de Nīmes

Status

Enrolling

Conditions

Renal Insufficiency, Chronic

Study type

Observational

Funder types

Other

Identifiers

NCT02938611
NIMAO/2016-06/OM-01

Details and patient eligibility

About

The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.

Enrollment

3,375 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • chronic kidney disease (stage >= 4)

Exclusion criteria

Trial design

3,375 participants in 1 patient group

The study population
Description:
Persons with stage \>=4 chronic kidney disease.

Trial contacts and locations

4

Loading...

Central trial contact

Olivier Moranne, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems